Jpmorgan Chase & CO Veru Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Veru Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 58,475 shares of VERU stock, worth $39,763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,475
Previous 56,386
3.7%
Holding current value
$39,763
Previous $47,000
4.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding VERU
# of Institutions
123Shares Held
56.8MCall Options Held
668KPut Options Held
531K-
Adage Capital Partners Gp, L.L.C. Boston, MA7.86MShares$5.35 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.65MShares$5.2 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY7.28MShares$4.95 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.2MShares$4.22 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.55MShares$3.78 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $54.5M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....